Organization
Los Angeles Medical Center
18 abstracts
Abstract
Survival benefit of autologous transplant (ASCT) for mantle cell lymphoma (MCL) in the California Cancer Registry (CCR).Org: Los Angeles Medical Center,
Abstract
Toxicity differences in CDK 4/6 inhibitors seen in Asian and Pacific Islanders.Org: University of California Irvine, Los Angeles Medical Center, University of Hawaii Cancer Center, Honolulu, HI,
Abstract
First- and second-line biomarker utilization in non-small cell lung cancer.Org: Cedars-Sinai Medical Center, Los Angeles Medical Center, CanSino Biologics,
Abstract
Time to target TIM-3 in colorectal cancer: TIM-3 expression to predict survival outcomes in patients in CALGB (Alliance)/SWOG 80405.Org: Norris Comprehensive Cancer Center, University of Southern California Marshall School of Business, Los Angeles Medical Center, Keck School of Medicine of the University of Southern California, Department of Population and Public Health Sciences,
Abstract
Costs and access barriers to ondansetron: A national analysis of Medicare part D and Medicare Advantage plans.Org: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Dallas, TX, UT Southwestern Medical Center,
Abstract
Determinants of resistance to nivolumab (nivo) monotherapy investigated through genomic and transcriptomic analysis of renal cell carcinoma (RCC) tumors from the HCRN GU16-260 study.Org: School of Medicine, Zhejiang University, Hangzhou, China, Yale University, New Haven, CTI BioPharma, Keck School of Medicine of the University of Southern California,
Abstract
A phase 1 study of AGEN2373, a novel CD137 agonist antibody designed to avoid hepatoxicity, in patients with advanced solid tumors.Org: Mary Crowley Cancer Research Center, Dallas, Next Oncology Virginia and Virginia Cancer Specialists, San Antonio Breast Cancer Symposium, Northwell Health Cancer Institute,
Abstract
The role of metabolic perturbations in mediating the effects of ambient air pollution on lung cancer in the cancer prevention studies.Org: Emory University, Atlanta, GA, USA, Atlanta Cancer Care, Galderma R&D, American Cancer Society - BrightEdge, American Cancer Society,
Abstract
Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.Org: City of Hope Comprehensive Cancer Center, Duarte, CA, Cedars-Sinai Cancer Center, Los Angeles Medical Center,
Abstract
Translated consent documents (CDs) and use in non-industry sponsored studies (NISS).Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, UCLA Department of Medicine, Los Angeles Medical Center, CanSino Biologics,
Abstract
Identification of a novel class of early exon ALK rearrangements across two pan tumor sequencing databases.Org: Cedars-Sinai Medical Center, Los Angeles Medical Center, CanSino Biologics, Tempus Labs, Inc., Chicago, IL,
Abstract
Network-enabled rapid growth of a US-based remote asynchronous oncology subspecialist case review service.Org: City of Hope National Medical Center, Duarte, CA, City of Hope Cancer Center, AccessHope, Los Angeles Medical Center,
Abstract
Immune checkpoint inhibitor effects on male reproduction.Org: Harbor-UCLA Medical Center, Torrance, CanSino Biologics, The Lundquist Institute, City of Hope Comprehensive Cancer Center,
Abstract
Impact of a pathologist-driven molecular testing protocol on veterans with non-small cell lung cancer.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of California Irvine, Los Angeles Medical Center, West Los Angeles VA Health Care System, University of California Los Angeles Medical Center/Veterans Affairs,
Abstract
ADALIMUMAB-INDUCED NONCASEATING GRANULOMA IN THE BONE MARROW OF A PATIENT BEING TREATED FOR RHEUMATOID ARTHRITISOrg: Medical student, McMaster University and Juravinski Cancer Centre, Hamilton Health Sciences, Canada's Michael Smith Genome Sciences Centre, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland,
Abstract
A SYSTEMATIC ANALYSIS OF CIRCULATING B CELL POPULATIONS IN HEALTHY AND SLE SUBJECTSOrg: Clinical Immunology Unit, Dept. of Medicine, Department of Pathology, Rogaland Central Hospital, Stavanger, Norway, Amgen, Thousand Oaks, Cedars-Sinai Medical Center, Los Angeles Medical Center,
Abstract
BELIMUMAB (BMAB), A FULLY HUMAN MONOCLONAL ANTIBODY TO B-LYMPHOCYTE STIMULATOR (BLYS), SHOWS BIOACTIVITY AND REDUCES SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITYOrg: LBSL02 Study Grp, Cedars-Sinai Comprehensive Cancer Center, UCLA Department of Medicine, Los Angeles Medical Center, UA AHSC,
Abstract
BELIMUMAB (FULLY HUMAN MONOCLONAL ANTIBODY TO BLYS) IMPROVED OR STABILIZED SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY AND REDUCED FLARE RATE DURING 3 YEARS OF THERAPYOrg: NSLIJHS, Lake Success, NY, Lake Success, NY, JHU, Baltimore, Cedars-Sinai Comprehensive Cancer Center,